Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits

International Journal of Experimental Pathology

Volumn 91, Issue 3, 2010, Pages 235-243

  Kang, Pengde ^a   Gao, Hong ^b   Pei, Fuxing ^a   Shen, Bin ^a   Yang, Jing ^a   Zhou, Zongke ^a  

^a SICHUAN UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Corticosteroid; Enoxaparin; Lovastatin; Osteonecrosis; Rabbits

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ENOXAPARIN; LIPID; MEPREDNISONE; MEVINOLIN; STEROID;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE NECROSIS; CELL SIZE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EXPERIMENTAL RABBIT; FEMUR; HISTOPATHOLOGY; HUMERUS; INCIDENCE; LIPID BLOOD LEVEL; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTICOAGULANTS; BONE MARROW CELLS; CHOLESTEROL; ENOXAPARIN; FATTY ACIDS, NONESTERIFIED; GLUCOCORTICOIDS; LOVASTATIN; MALE; METHYLPREDNISOLONE; OSTEONECROSIS; RABBITS; TRIGLYCERIDES;

EID: 77952680693     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2010.00705.x     Document Type: Article

References (40)

1. Arlet J., Durroux R., Fauchier C., Thiechart M. (1984) Histopathology of nontraumatic necrosis of the femoral head: topographic and evolutive aspects. In : Bone Circulation, pp. 296 305 (eds J. Arlet, R.P. Ficat, D.S. Hungerford
2. Asano T., Takahashi K.A., Fujioka M. et al. (2003) ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation. Pharmacogenetics 13, 675 682.
3. Chao Y.C., Wang S.J., Chu H.C., Chang W.K., Hsieh T.Y. (2003) Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. Alcohol 38, 431 436.
4. Chemetsky S.G., Mont M.A., LaPorte D.M., Jones L.C., Hungerford D.S., McCarthy E.F. (1999) Pathologic features in steroid and nonsteroid associated osteonecrosis. Clin. Orthop. Relat. Res. 368, 149 161.
5. Cui Q., Wang G.J., Su C.C. (1997) The Otto Aufranc award: lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin. Orthop. Relat. Res. 344, 8 19.
6. Emmanucle L., Ortmann J., Doerflinger T., Traupe T., Barton M. (2003) Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein- stimulated cell growth. Biochem. Biophys. Res. Commun. 302, 67 72.
7. Glueck C.J., Freiberg R.A., Fontaine R.N., Tracy T., Wang P. (2001) Hypofibinolysis, thrombophilia, osteonectosis. Clin. Orthop. Relat. Res. 386, 19 33.
8. Glueck C.J., Freiberg R.A., Sieve L., Wang P. (2005) Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin. Orthop. Relat. Res. 435, 164 170.
9. Hernigou P. Beaujean F. (1997) Abnormalities in the bone marrow of the iliac crest in patients who have osteonecrosis secondary to corticosteroid therapy or alcohol abuse. J. Bone Joint Surg. Am. 79, 1047 1053.
10. Hirano K., Tsutsui H., Sugioka Y., Sueishi K. (1997) Histopathologic alterations of retinacular vessels and osteonecrosis. Clin. Orthop. Relat. Res. 324, 192 204.
11. Hungerford D.S. (2007) Treatment of osteonecrosis of the femoral head: everything's new. J. Arthroplasty 22 (4 Suppl. 1 91 94.
12. Hungford D.S. Lennox D.W. (1985) The importance of increased intraosseous pressure in the development of osteonecrosis of the femoral head: implications for treatment. Orthop. Clin. North Am. 16, 635 654.
13. Jones J.P. Jr. (1993) Fat embolism, intravascular coagulation and osteonecrosis. Clin. Orthop. Relat. Res. 292, 294 308.
14. Kang P.D., Pei F.X., Shen B., Yang J., Zhou Z.K., Cheng J.Q. (2008) Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine 75, 696 701.
15. Koo K.H., Dussalt R.G., Kaplan P.A. et al. (1999) Fatty marrow conversion of the proximal femoral metaphysic in osteonecrosis hips. Clin. Orthop. Relat. Res. 361, 159 167.
16. Lafforgue P. (2006) Pathophsiology and natural history of avascular necrosis of bone. Joint Bone Spine 73, 500 507.
17. Lee K., Park S.Y., Lee D.H., Kim H. (2002) Lovastatin increases longitudinal bone growth and bone morphogenetic protein-2 levels in the growth plate of Sprague-Dawley rats. Eur. J. Pediatr. 161, 406 407.
18. Lemoine A. (1957) Vascular changes after interference with the blood flow of the femoral head of the rabbit. J. Bone Joint Surg. Br. 39, 763 777.
19. Li X.D., Cui Q., Kao C.H., Wang G.J., Balian G. (2003) Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPAR2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33, 652 659.
20. Lieberman J.R., Berry D.J., Mont M.A. et al. (2002) Osteonecrosis of the hip: management in the twenty-first century. J. Bone Joint Surg. Am. 84, 834 853.
21. Liu Y.F., Chen W.M., Lin Y.F. et al. (2005) Type II collagen gene variants and inherited osteonecrosis of the femoral head. N. Engl. J. Med. 352, 2294 2301.
22. Mankin H.J. (1992) Nontraumatic necrosis of bone (osteonecrosis). N. Engl. J. Med. 326, 1473 1479.
23. Masada T., Iwakiri K., Oda Y. et al. (2008) Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model. J. Orthop. Res. 26, 91 95.
24. Matsui M., Saito S., Ohzono K. (1992) Experimental steroid-induced osteonecrosis in adult rabbits with hypersensitivity vasculitis. Clin Orthop. 277, 61 72.
25. Miyanishi K., Yamamoto T., Irisa T. et al. (2002) Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 30, 185 190.
26. Miyanishi K., Yamamoto T., Irisa T. et al. (2005) Effects of different corticosteroids on the development of osteonecrosis in rabbits. Rheumatology (Oxford) 44, 332 336.
27. Mont M.A., Jones L.C., Hungerford D.S. (2006) Current concepts review nontraumatic osteonecrosis of the femoral head: ten years later. J. Bone Joint Surg. Am. 88, 1117 1132.
28. Motomura G., Yamamoto T., Miyanishi K., Jingushi S., Iwamoto Y. (2004) Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Am Coll of Rheumatol. 110, 3387 3391.
29. Mundy G., Garrett R., Harris S. et al. (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286, 1946 1949.
30. Ortiguera C.J., Pulliam I.T., Cabanela M.E. (1999) Total hip arthroplasty for osteonecrosis: matched-pair analysis of 188 hips with long-term followup. J. Arthroplasty 14, 21 28.
31. Parfitt A.M., Drezner M.K., Glorieux F.H. (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. J. Bone Miner. Res. 2, 595 610.
32. Pengde K., Bin S., Jing Y., Fuxing P. (2008) Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head. Thromb. Res. 123, 367 373.
33. Roy D.R. Glueck C.J. (1999) Osteonecrosis, medical management. J. Rheumatol. 2, 260 261.
34. Shaw S.L., Salmon E.D., Quatrano R.S. (1995) Digital photography for the light microscope: results with a gated, video-rate CCD camera and NIH-image software. BioTechniques 19, 946 955.
35. Wang G.J. (1992) Pathogenesis of steroid-induced avascular necrosis and its response to lipid clearing agents. In : Trends in Research and Treatment of Joint Diseases, pp. 59 71 (eds K. Hirohata, K. Mizuno, T. Matsubara
36. Wang G.J., Moga D.B., Richemer W.G., Sweet D.E., Reger S.L., Thompson R.C. (1978) Cortisone induced bone changes and its response to lipid clearing aagents. Clin. Orthop. Relat. Res. 130, 81 85.
37. Wang G.J., Cui Q., Balian G. (2000) The pathogenesis and prevention of steroid induced osteonecrosis. Clin. Orthop. Relat. Res. 370, 295 310.
38. Xenakis T.A., Beris A.E., Malizoa K.K. (1997) Total hip arthroplasty for avascular necrosis and degenerative osteoarthritis of the hip. Clin. Orthop. Relat. Res. 341, 62 68.
39. Yamamoto T., Irisa T., Sugioka Y., Sueishi K. (1997) Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum. 40, 2055 2064.
40. Zizic T.M., Marcoux C., Hungerford D.S., Stevens M.B. (1997) The early diagnosis of ischemic necrosis of bone. Arthritis Rhrum. 40, 2055 2064.